Re. Cantech letter
Good find.
The past two weeks interest has picked up dramatically in ICO. Over 2m shares traded and being bought by a diverse group (Jordan, RBC, TD and Anonymous doing the heavy lifting) of buyers.
Of note, as per their first clinical update on the iDEAL 007 trial in January, 149 patients had initiated dosing at that time. As we are now in September, all 149 of those patients would be completely through the dosing stage(8 months in length), which would work out to roughly 75% of the total trial participants. The primary endpoint of the iDEAL trial is a change in visual acuity from baseline to month eight, meaning you better believe that the evidence is now mounting in a VERY meaningful way and we are getting CLOSE!
My guess is we breach the mid $.50's next week and by the end of October we pass our previous highs. We are too advanced at this stage not to be on some very influential radars and we are slowly hitting a critical mass in terms of getting an explosive rally started.